Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine

• Status: Completed
• Trial end date: 2017-12-30
• Target enrollment: 0
• Participant gender: Female

Summary

This randomized controlled trial, compared postoperative pain score in patient undergoing cesarean delivery between bupivacaine peritoneal and subcutaneous infiltration and diclofenac intramuscular injection

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rajavithi Hospital
• Treatments: Bupivacaine; Diclofenac

Criteria

Inclusion Criteria:

• Patients undergo elective or urgency cesarean delivery at Rajavithi Hospital in 2016-2017

• Urgency conditions: CPD, fail induction of labor, antepartum hemorrhage without hypovolemic shock, dystocia, previous cesarean section and active labor, malpresentation in labor, macrosomic presentation in labor

• Pregnant women more than 20 years of age

• Gestational age more than 37 week

• Cesarean section under regional or general anesthesia

• Ability to communicating, writing and reading Thai language

Exclusion Criteria:

• Inability to communicating or writing or reading Thai language

• Contraindicated to bupivacaine or diclofenac or morphine

• Pregnant women with emergency conditions

• Have one or more complication of pregnancy

• Intraoperative arrhythmia

• Pregnant women less than 20 years of age

• Regional anesthesia with morphine